Cardiovascular disease risk of abdominal obesity vs. metabolic abnormalities

Rachel P. Wildman, Aileen P. McGinn, Juan Lin, Dan Wang, Paul Muntner, Hillel W. Cohen, Kristi Reynolds, Vivian Fonseca, Maryfran R. Sowers

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

It remains unclear whether abdominal obesity increases cardiovascular disease (CVD) risk independent of the metabolic abnormalities that often accompany it. Therefore, the objective of this study was to evaluate the independent effects of abdominal obesity vs. metabolic syndrome and diabetes on the risk for incident coronary heart disease (CHD) and stroke. The Framingham Offspring, Atherosclerosis Risk in Communities, and Cardiovascular Health studies were pooled to assess the independent effects of abdominal obesity (waist circumference 102cm for men and 88cm for women) vs. metabolic syndrome (excluding the waist circumference criterion) and diabetes on risk for incident CHD and stroke in 20,298 men and women aged 45 years. The average follow-up was 8.3 (s.d. 1.9) years. There were 1,766 CVD events. After adjustment for demographic factors, smoking, alcohol intake, number of metabolic syndrome components, and diabetes, abdominal obesity was not significantly associated with an increased risk of CVD (hazard ratio (HR) (95% confidence interval): 1.09 (0.98, 1.20)). However, after adjustment for demographics, smoking, alcohol intake, and abdominal obesity, having 1-2 metabolic syndrome components, the metabolic syndrome and diabetes were each associated with a significantly increased risk of CVD (2.12 (1.80, 2.50), 2.82 (1.92, 4.12), and 5.33 (3.37, 8.41), respectively). Although abdominal obesity is an important clinical tool for identification of individuals likely to possess metabolic abnormalities, these data suggest that the metabolic syndrome and diabetes are considerably more important prognostic indicators of CVD risk.

Original languageEnglish (US)
Pages (from-to)853-860
Number of pages8
JournalObesity
Volume19
Issue number4
DOIs
StatePublished - Apr 2011

Fingerprint

Abdominal Obesity
Cardiovascular Diseases
Waist Circumference
Coronary Disease
Smoking
Stroke
Alcohols
Demography
Atherosclerosis
Confidence Intervals
Health

ASJC Scopus subject areas

  • Endocrinology
  • Medicine (miscellaneous)
  • Endocrinology, Diabetes and Metabolism
  • Nutrition and Dietetics

Cite this

Wildman, R. P., McGinn, A. P., Lin, J., Wang, D., Muntner, P., Cohen, H. W., ... Sowers, M. R. (2011). Cardiovascular disease risk of abdominal obesity vs. metabolic abnormalities. Obesity, 19(4), 853-860. https://doi.org/10.1038/oby.2010.168

Cardiovascular disease risk of abdominal obesity vs. metabolic abnormalities. / Wildman, Rachel P.; McGinn, Aileen P.; Lin, Juan; Wang, Dan; Muntner, Paul; Cohen, Hillel W.; Reynolds, Kristi; Fonseca, Vivian; Sowers, Maryfran R.

In: Obesity, Vol. 19, No. 4, 04.2011, p. 853-860.

Research output: Contribution to journalArticle

Wildman, RP, McGinn, AP, Lin, J, Wang, D, Muntner, P, Cohen, HW, Reynolds, K, Fonseca, V & Sowers, MR 2011, 'Cardiovascular disease risk of abdominal obesity vs. metabolic abnormalities', Obesity, vol. 19, no. 4, pp. 853-860. https://doi.org/10.1038/oby.2010.168
Wildman, Rachel P. ; McGinn, Aileen P. ; Lin, Juan ; Wang, Dan ; Muntner, Paul ; Cohen, Hillel W. ; Reynolds, Kristi ; Fonseca, Vivian ; Sowers, Maryfran R. / Cardiovascular disease risk of abdominal obesity vs. metabolic abnormalities. In: Obesity. 2011 ; Vol. 19, No. 4. pp. 853-860.
@article{15cffa8b5b9a41758397bda8355d96fc,
title = "Cardiovascular disease risk of abdominal obesity vs. metabolic abnormalities",
abstract = "It remains unclear whether abdominal obesity increases cardiovascular disease (CVD) risk independent of the metabolic abnormalities that often accompany it. Therefore, the objective of this study was to evaluate the independent effects of abdominal obesity vs. metabolic syndrome and diabetes on the risk for incident coronary heart disease (CHD) and stroke. The Framingham Offspring, Atherosclerosis Risk in Communities, and Cardiovascular Health studies were pooled to assess the independent effects of abdominal obesity (waist circumference 102cm for men and 88cm for women) vs. metabolic syndrome (excluding the waist circumference criterion) and diabetes on risk for incident CHD and stroke in 20,298 men and women aged 45 years. The average follow-up was 8.3 (s.d. 1.9) years. There were 1,766 CVD events. After adjustment for demographic factors, smoking, alcohol intake, number of metabolic syndrome components, and diabetes, abdominal obesity was not significantly associated with an increased risk of CVD (hazard ratio (HR) (95{\%} confidence interval): 1.09 (0.98, 1.20)). However, after adjustment for demographics, smoking, alcohol intake, and abdominal obesity, having 1-2 metabolic syndrome components, the metabolic syndrome and diabetes were each associated with a significantly increased risk of CVD (2.12 (1.80, 2.50), 2.82 (1.92, 4.12), and 5.33 (3.37, 8.41), respectively). Although abdominal obesity is an important clinical tool for identification of individuals likely to possess metabolic abnormalities, these data suggest that the metabolic syndrome and diabetes are considerably more important prognostic indicators of CVD risk.",
author = "Wildman, {Rachel P.} and McGinn, {Aileen P.} and Juan Lin and Dan Wang and Paul Muntner and Cohen, {Hillel W.} and Kristi Reynolds and Vivian Fonseca and Sowers, {Maryfran R.}",
year = "2011",
month = "4",
doi = "10.1038/oby.2010.168",
language = "English (US)",
volume = "19",
pages = "853--860",
journal = "Obesity",
issn = "1930-7381",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - Cardiovascular disease risk of abdominal obesity vs. metabolic abnormalities

AU - Wildman, Rachel P.

AU - McGinn, Aileen P.

AU - Lin, Juan

AU - Wang, Dan

AU - Muntner, Paul

AU - Cohen, Hillel W.

AU - Reynolds, Kristi

AU - Fonseca, Vivian

AU - Sowers, Maryfran R.

PY - 2011/4

Y1 - 2011/4

N2 - It remains unclear whether abdominal obesity increases cardiovascular disease (CVD) risk independent of the metabolic abnormalities that often accompany it. Therefore, the objective of this study was to evaluate the independent effects of abdominal obesity vs. metabolic syndrome and diabetes on the risk for incident coronary heart disease (CHD) and stroke. The Framingham Offspring, Atherosclerosis Risk in Communities, and Cardiovascular Health studies were pooled to assess the independent effects of abdominal obesity (waist circumference 102cm for men and 88cm for women) vs. metabolic syndrome (excluding the waist circumference criterion) and diabetes on risk for incident CHD and stroke in 20,298 men and women aged 45 years. The average follow-up was 8.3 (s.d. 1.9) years. There were 1,766 CVD events. After adjustment for demographic factors, smoking, alcohol intake, number of metabolic syndrome components, and diabetes, abdominal obesity was not significantly associated with an increased risk of CVD (hazard ratio (HR) (95% confidence interval): 1.09 (0.98, 1.20)). However, after adjustment for demographics, smoking, alcohol intake, and abdominal obesity, having 1-2 metabolic syndrome components, the metabolic syndrome and diabetes were each associated with a significantly increased risk of CVD (2.12 (1.80, 2.50), 2.82 (1.92, 4.12), and 5.33 (3.37, 8.41), respectively). Although abdominal obesity is an important clinical tool for identification of individuals likely to possess metabolic abnormalities, these data suggest that the metabolic syndrome and diabetes are considerably more important prognostic indicators of CVD risk.

AB - It remains unclear whether abdominal obesity increases cardiovascular disease (CVD) risk independent of the metabolic abnormalities that often accompany it. Therefore, the objective of this study was to evaluate the independent effects of abdominal obesity vs. metabolic syndrome and diabetes on the risk for incident coronary heart disease (CHD) and stroke. The Framingham Offspring, Atherosclerosis Risk in Communities, and Cardiovascular Health studies were pooled to assess the independent effects of abdominal obesity (waist circumference 102cm for men and 88cm for women) vs. metabolic syndrome (excluding the waist circumference criterion) and diabetes on risk for incident CHD and stroke in 20,298 men and women aged 45 years. The average follow-up was 8.3 (s.d. 1.9) years. There were 1,766 CVD events. After adjustment for demographic factors, smoking, alcohol intake, number of metabolic syndrome components, and diabetes, abdominal obesity was not significantly associated with an increased risk of CVD (hazard ratio (HR) (95% confidence interval): 1.09 (0.98, 1.20)). However, after adjustment for demographics, smoking, alcohol intake, and abdominal obesity, having 1-2 metabolic syndrome components, the metabolic syndrome and diabetes were each associated with a significantly increased risk of CVD (2.12 (1.80, 2.50), 2.82 (1.92, 4.12), and 5.33 (3.37, 8.41), respectively). Although abdominal obesity is an important clinical tool for identification of individuals likely to possess metabolic abnormalities, these data suggest that the metabolic syndrome and diabetes are considerably more important prognostic indicators of CVD risk.

UR - http://www.scopus.com/inward/record.url?scp=79953174580&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79953174580&partnerID=8YFLogxK

U2 - 10.1038/oby.2010.168

DO - 10.1038/oby.2010.168

M3 - Article

C2 - 20725064

AN - SCOPUS:79953174580

VL - 19

SP - 853

EP - 860

JO - Obesity

JF - Obesity

SN - 1930-7381

IS - 4

ER -